Penicillin-Streptomycin is used to supplement cell culture media to control bacterial contamination.
Penicillin streptomycin solution has been used as a supplement in different types of media, including RGC (retinal ganglion cells) culture, α-MEM (minimum essential medium) growth medium, Dulbecco′s modified Eagle′s medium (DMEM)/nutrient mixture F-12 Ham, DMEMand DMEM/F-12 + GlutaMax.
In 2018, the global Penicillin and Streptomycin market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Penicillin and Streptomycin status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Penicillin and Streptomycin development in United States, Europe and China.

The key players covered in this study
Astellas Pharma
GlaxoSmithKline
MiddleBrook Pharmaceuticals
Johnson & Johnson
Merck
Gilead Sciences
Toyama Chemical
Eli Lilly
Astra Zeneca
Takeda Pharmaceutical

Market segment by Type, the product can be split into
Penicillin
Streptomycin

Market segment by Application, split into
Throat Infections
Meningitis
Tuberculosis Treatment

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Penicillin and Streptomycin status, future forecast, growth opportunity, key market and key players.
To present the Penicillin and Streptomycin development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Penicillin and Streptomycin are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.